CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Welcome to Capital.com. The products and services listed on this website are not available to US residents.

Trade Assembly Biosciences, Inc. - ASMB CFD

15.1189
3.2%
Swap Long:
74 %
Swap Short:
26 %
  • Summary
  • Historical Data
Trading сonditions
Spread 0.1722
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023374 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023374%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001151 %
Charges from full value of position ($0.22)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001151%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 15.6189
Open 15.6689
1-Year Change 1980.86%
Day's Range 14.9589 - 15.9989
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 20, 2024 15.1189 -0.3900 -2.51% 15.5089 16.0089 14.8489
Dec 19, 2024 15.6189 -0.2400 -1.51% 15.8589 16.4789 14.7089
Dec 18, 2024 13.4689 -1.4900 -9.96% 14.9589 14.9689 13.0889
Dec 17, 2024 14.1789 -0.4800 -3.27% 14.6589 15.1089 14.0989
Dec 16, 2024 15.2089 0.2400 1.60% 14.9689 15.7589 14.8389
Dec 13, 2024 15.2089 0.2500 1.67% 14.9589 15.3589 14.9289
Dec 12, 2024 15.0689 -0.0900 -0.59% 15.1589 15.2089 14.8589
Dec 11, 2024 14.9789 -0.7300 -4.65% 15.7089 15.7089 14.4989
Dec 10, 2024 15.8189 -0.1600 -1.00% 15.9789 16.4589 15.7089
Dec 9, 2024 16.4289 0.6400 4.05% 15.7889 16.9489 15.7889
Dec 6, 2024 16.0089 -0.2100 -1.29% 16.2189 16.4089 15.6989
Dec 5, 2024 16.0989 0.1400 0.88% 15.9589 16.3789 15.9589
Dec 4, 2024 16.2289 -0.2100 -1.28% 16.4389 16.4389 15.9189
Dec 3, 2024 16.1989 -0.3700 -2.23% 16.5689 16.5689 15.4589
Dec 2, 2024 16.6689 -0.3400 -2.00% 17.0089 17.2089 16.4589
Nov 29, 2024 16.9889 0.4800 2.91% 16.5089 17.1589 16.5089
Nov 27, 2024 16.2889 1.1100 7.31% 15.1789 16.6789 15.1689
Nov 26, 2024 14.9989 -0.1900 -1.25% 15.1889 15.4689 14.7589
Nov 25, 2024 14.7689 -0.1000 -0.67% 14.8689 15.4789 14.6389
Nov 22, 2024 14.9689 0.2900 1.98% 14.6789 15.1189 14.3489

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

680K+

Traders

101K+

Active clients monthly

$215B+

Monthly trading volume

$46M+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Assembly Biosciences, Inc. Company profile

About Assembly Biosciences Inc

Assembly Biosciences, Inc. is a clinical-stage biotechnology company advancing a class of oral therapeutic candidates for the treatment of chronic hepatitis B virus (HBV) infection. The Company’s inhibitor product candidates include Vebicorvir (VBR), ABI-H2158 (2158), and ABI-H3733 (3733). Vebicorvir (VBR) is licensed from Indiana University and treating patients with VBR plus nucelos(t)ide analog reverse transcriptase inhibitors (NrtIs) and ultimately transitioning patients. ABI-H2158 (2158) is chemically distinct from VBR. ABI-H3733 (3733) for chronic HBV infection in the People’s Republic of China, Hong Kong, Taiwan and Macau (the Territory). The Company’s research and development programs pursuing multiple drug candidates that inhibit the HBV replication cycle and block the generation of covalently closed circular DNA (cccDNA), to discover and develop finite and curative therapies for patients with HBV.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Assembly Biosciences Inc revenues decreased 92% to $6.3M. Net loss increased from $62.2M to $129.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Interest and other income, net decrease of 88% to $302K (income), Restructuring Charges & Provisions increase of 40% to $277K (expense).

Equity composition

Common Stock $0.001 Par, 4/11, 25M auth., 7,189,706 issd.insider control 7.88%. 07-14, 1-for-5 reverse stock split.

Industry: Proprietary & Advanced Pharmaceuticals

Two Tower Place
7Th Floor
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

People also watch

Gold

2,623.59 Price
+1.110% 1D Chg, %
Swap short:
74 %
Swap long:
26 %
Long position overnight fee -0.0151%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,269.40 Price
+0.710% 1D Chg, %
Swap short:
74 %
Swap long:
26 %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 7.0

ETH/USD

3,409.67 Price
-0.730% 1D Chg, %
Swap short:
74 %
Swap long:
26 %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

BTC/USD

97,409.10 Price
+0.880% 1D Chg, %
Swap short:
74 %
Swap long:
26 %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading